CV Sciences, Inc. (CVSI)
OTCMKTS · Delayed Price · Currency is USD
0.0404
+0.0024 (6.26%)
Aug 22, 2025, 3:22 PM EDT
CV Sciences Market Cap
CV Sciences has a market cap or net worth of $7.00 million as of August 22, 2025. Its market cap has decreased by -22.78% in one year.
Market Cap
7.00M
Enterprise Value
7.82M
Revenue
14.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.04
Market Cap Chart
Since November 9, 2011, CV Sciences's market cap has increased from 3.71M to 7.00M, an increase of 88.73%. That is a compound annual growth rate of 4.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2025 | 7.37M | 18.34% |
| Dec 31, 2024 | 6.23M | 13.96% |
| Dec 29, 2023 | 5.47M | 10.51% |
| Dec 30, 2022 | 4.95M | -62.06% |
| Dec 31, 2021 | 13.04M | -72.32% |
| Dec 31, 2020 | 47.10M | -50.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 832.17M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 626.52M |
| Elite Pharmaceuticals | 603.43M |
| CytoDyn | 363.56M |
| American Oncology Network | 355.44M |
| Northwest Biotherapeutics | 352.80M |